NCT03927209View on ClinicalTrials.gov

A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain.

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 6, 2019

Primary Completion Date

November 22, 2019

Study Completion Date

November 22, 2019

Conditions
Healthy
Interventions
DRUG

BI 1467335

tablet

Trial Locations (1)

HA1 3UJ

Northwick Park Hospital, Harrow

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY